$ATRA Atara Biotherapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Atara Biotherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Atara Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Atara Biotherapeutics, Inc. for free.

CIK Number: 0001604464
IRS Number: 460920988
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ATRA
Company Address: 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO 94080

Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.

Market Capitalization: $434.34M
Prev close: $15.05
Average Daily Volume: 231,402
Days Low: $14.70
Year Low: $12.45
Year High: $25.73

Atara Biotherapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Dupont JakobEVP, Head of R&D46,250696,063shares bought: 46,250 / shares sold: 0 BUYMay 19 202010 days ago
Koppikar UtpalChief Financial Officer137,3752,067,494shares bought: 140,938 / shares sold: -5,036 STRONG BUYMay 20 20209 days ago
Murugan AmarSVP, GC & Secretary55,000827,750shares bought: 55,000 / shares sold: 0 BUYApr 21 20201 month ago
Newell JoeChief Operations Officer123,8811,864,409shares bought: 69,500 / shares sold: -55,619 BUYMay 20 20209 days ago
Renaud Ronald C JRDirector00Apr 30 202029 days ago
Roncarolo Maria GraziaDirector00May 12 202017 days ago
Touchon PascalPresident and CEO276,9794,168,534shares bought: 140,074 / shares sold: -13,095 BUYMay 20 20209 days ago

View all Atara Biotherapeutics, Inc. insiders.

Atara Biotherapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 20 2020ATRAAtara Biotherapeut ...Newell JoeChief Operations Of ...SellS11.221,60317,986123,881125.5 K to 123.9 K (-1.28 %)
May 20 2020ATRAAtara Biotherapeut ...Koppikar UtpalChief Financial Off ...SellS11.221,42816,022137,375138.8 K to 137.4 K (-1.03 %)
May 20 2020ATRAAtara Biotherapeut ...Touchon PascalPresident and CEOSellS11.223,19535,848276,979280.2 K to 277 K (-1.14 %)
May 19 2020ATRAAtara Biotherapeut ...Dupont JakobEVP, Head of R&DOption ExerciseA9.58277,5002,658,450277,500
May 19 2020ATRAAtara Biotherapeut ...Dupont JakobEVP, Head of R&DGrantA0.0046,250046,2500 to 46.3 K
May 12 2020ATRAAtara Biotherapeut ...Roncarolo Maria GraziaDirectorOption ExerciseA10.2559,500609,87559,500
Apr 30 2020ATRAAtara Biotherapeut ...Renaud Ronald C JRDirectorOption ExerciseA8.5371,500609,89571,500
Apr 21 2020ATRAAtara Biotherapeut ...Murugan AmarSVP, GC & SecretaryOption ExerciseA8.20110,000902,000110,000
Apr 21 2020ATRAAtara Biotherapeut ...Murugan AmarSVP, GC & SecretaryGrantA0.0055,000055,0000 to 55 K
Apr 07 2020ATRAAtara Biotherapeut ...Newell JoeChief Operations Of ...SellS7.946575,217125,484126.1 K to 125.5 K (-0.52 %)
Mar 30 2020ATRAAtara Biotherapeut ...Koppikar UtpalChief Financial Off ...SellS9.171,82716,754137,330139.2 K to 137.3 K (-1.31 %)
Mar 30 2020ATRAAtara Biotherapeut ...Newell JoeChief Operations Of ...SellS9.172,74025,126126,141128.9 K to 126.1 K (-2.13 %)
Mar 03 2020ATRAAtara Biotherapeut ...Koppikar UtpalChief Financial Off ...Option ExerciseA12.1573,750896,06373,750
Mar 03 2020ATRAAtara Biotherapeut ...Koppikar UtpalChief Financial Off ...GrantA0.0066,8750139,15772.3 K to 139.2 K (+92.52 %)
Feb 19 2020ATRAAtara Biotherapeut ...Yarema KristinChief Commercial Of ...Option ExerciseA14.56110,0001,601,600110,000

View all Atara Biotherapeutics, Inc. insider transactions.